Bliv Tirzepatide Review: Cost, the Unknowable Rate & Honest Verdict (2026)

Bliv advertises tirzepatide "as low as $199/month," — but that figure is explicitly footnoted "based on plan structure and eligibility," and the plan selector sits behind the medical intake. In plain terms: you can't learn your actual rate until after you've handed over a medical history. Every fact here comes from the company's own published program.

What Bliv is

Bliv is a telehealth provider, selling personalized compounded GLP-1 programs — both semaglutide and tirzepatide. An online intake is reviewed by a licensed clinician, and the advertised price is shown before you start that intake, though the actual rate you're offered is not.

The rate you can't know in advance

This is the most important thing to understand about Bliv's pricing: "$199/month" is an "as low as" figure, footnoted as varying by plan structure and eligibility, and the actual plan you're offered only appears after you've completed the medical intake. You're effectively committing your medical history before learning your real price.

Fees beyond the headline rate

A $24.99 provider consultation fee is charged on top of the plan price, and Bliv's own refund policy deducts $200 for "clinical coordination and account setup" if you don't proceed. Klarna and CareCredit financing options are offered, with installments as low as $29 — that figure is a financing payment, not the price of a month of medication, and shouldn't be confused with the headline rate.

The cancellation-fee contradiction

Bliv's homepage advertises "no long-term commitments or cancellation fees," — but its own terms require the membership fee to be paid "in a single sum," call it non-refundable, and refer to a "Membership Term", language that sits uneasily next to the no-commitment homepage pitch. Read the actual terms, not just the homepage, before signing up.

The brand-vs-compounded question

Bliv dispenses compounded tirzepatide, not the FDA-approved branded product. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Bliv's real strength: both semaglutide and tirzepatide are available through a straightforward telehealth intake. The trade-offs are significant and worth reading closely: the advertised rate is unknowable until after you hand over a medical history, a $24.99 consultation fee applies on top, a $200 non-refundable deduction applies if you back out, and the homepage's "no cancellation fees" claim sits against membership terms that describe a non-refundable single-sum payment. As with any GLP-1 program, read the actual terms page — not just the marketing copy — before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Bliv's headline $199 rate is real, but it's structured so you can't confirm it applies to you until after committing your medical history — and the fine print includes a consultation fee, a non-refundable deduction, and cancellation-fee language that contradicts the homepage pitch. Read the terms page directly before starting the intake. If a genuinely known, published rate matters more to you, compare it against CoreAge Rx or bmiMD, both of which publish a specific number rather than an "as low as" range. See our best tirzepatide providers ranking for the full field.